Letting the target determine your compound acquisition strategy

Drug Discovery World

Volumn 10, Issue 2, 2009, Pages 19-22

  Harris, John ^a  

^a GALAPAGOS NV   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PHOSPHOTRANSFERASE INHIBITOR;

AMINO ACID SEQUENCE; ANALYTIC METHOD; ARTICLE; BIOTECHNOLOGY; CELL ASSAY; COMBINATORIAL LIBRARY; COMPUTER MODEL; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; CYTOTOXICITY; DRUG INDUSTRY; DRUG RESEARCH; DRUG SCREENING; DRUG SYNTHESIS; DRUG TARGETING; EPIGENETICS; GENOMICS; HIGH THROUGHPUT SCREENING; MOLECULAR BIOLOGY; PHYSICAL CHEMISTRY; RNA INTERFERENCE;

EID: 65349191258     PISSN: 14694344     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Sun, D et al. A Kinase-Focused Compound Collection: Compilation and Screening Strategy. Chem. Biol. Drug Discovery (2006) 67, 385-394.
2. Presented at 11th MipTec Conference, Basel, October 2008.
3. Christopher Hulme, presented at 237th ACS National Meeting, Salt Lake City March 22-26, 2009.